- Parties: The appellants were AbbVie Corporation and AbbVie Biotechnology Ltd. The respondents were the Minister of Health and Jamp Pharma Corporation.

- Subject Matter: The appellants sought to quash the Minister of Health's decision determining that the respondent was not a second person under s. 5(1) of the Patented Medicines (Notice of Compliance) Regulations, SOR/93-133 in relation to certain drug products.

- Date: The appeal filed in October 2022 was officially discontinued by the Appellant through a Notice of Discontinuance filed on April 3, 2024. This followed a scheduling order for a hearing set for April 9, 2024, which was subsequently not pursued. A motion for costs filed by the Respondent in May 2024 was later abandoned on July 29, 2024. The case is effectively closed, and no further proceedings are pending.

- Venue: This was a federal case before the Federal Court of Appeal.

- Amount: No financial award was specified.